Gilead Sciences Inc (GILD)
Pretax margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 6,912,000 | 7,284,000 | 7,393,000 | 7,311,000 | 5,840,000 | 4,567,000 | 5,576,000 | 5,886,000 | 8,302,000 | 9,358,000 | 6,746,000 | 1,958,000 | 1,703,000 | 1,790,000 | -540,000 | 4,841,000 | 5,182,000 | 4,290,000 | 8,450,000 | 8,119,000 |
| Revenue (ttm) | US$ in thousands | 26,229,000 | 26,516,000 | 26,520,000 | 26,161,000 | 26,413,000 | 26,256,000 | 26,613,000 | 26,496,000 | 26,325,000 | 26,743,000 | 26,144,000 | 25,341,000 | 24,689,000 | 23,147,000 | 22,174,000 | 22,716,000 | 22,449,000 | 22,365,000 | 22,357,000 | 22,320,000 |
| Pretax margin | 26.35% | 27.47% | 27.88% | 27.95% | 22.11% | 17.39% | 20.95% | 22.21% | 31.54% | 34.99% | 25.80% | 7.73% | 6.90% | 7.73% | -2.44% | 21.31% | 23.08% | 19.18% | 37.80% | 36.38% |
December 31, 2023 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $6,912,000K ÷ $26,229,000K
= 26.35%
Gilead Sciences, Inc.'s pretax margin has shown a positive trend over the quarters, with Q4 2023 exhibiting a slight decrease compared to the prior quarter but still remaining fairly strong at 25.30%. This indicates that the company is effectively controlling its operating costs and generating solid profits before taxes. The pretax margins in Q3 and Q2 of 2023 were also robust at 26.42% and 26.84%, respectively. The consistent performance in pretax margin throughout 2023 reflects Gilead's ability to efficiently manage its expenses while generating sufficient revenues. This steady improvement from the previous year's performance, especially notable when comparing to Q4 2022's pretax margin of 21.31%, indicates that the company is on a positive trajectory in terms of profitability and financial health.
Peer comparison
Dec 31, 2023